In This Issue FREE

Pharmacogenomics J 7: 221; doi:10.1038/sj.tpj.6500475

Abstract | Full Text | PDF

Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach

Z A Rodd, B A Bertsch, W N Strother, H Le-Niculescu, Y Balaraman, E Hayden, R E Jerome, L Lumeng, J I Nurnberger Jr, H J Edenberg, W J McBride and A B Niculescu

Pharmacogenomics J 7: 222-256; advance online publication, October 10, 2006; doi:10.1038/sj.tpj.6500420

Abstract | Full Text | PDF | Supplementary information

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication

J Kirchheiner, H Schmidt, M Tzvetkov, J-Tha Keulen, J Lötsch, I Roots and J Brockmöller

Pharmacogenomics J 7: 257-265; advance online publication, July 4, 2006; doi:10.1038/sj.tpj.6500406

Abstract | Full Text | PDF

The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms

J D Robinson, C Y Lam, J A Minnix, D W Wetter, G E Tomlinson, J D Minna, T T-L Chen and P M Cinciripini

Pharmacogenomics J 7: 266-274; advance online publication, December 26, 2006; doi:10.1038/sj.tpj.6500427

Abstract | Full Text | PDF

No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation

F M Theisen, M Haberhausen, M A Firnges, P Gregory, J H Reinders, H Remschmidt, J Hebebrand and J Antel

Pharmacogenomics J 7: 275-281; advance online publication, September 19, 2006; doi:10.1038/sj.tpj.6500418

Abstract | Full Text | PDF | Supplementary information

A novel polymorphism in the 17-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian men

J Jakobsson, E Palonek, M Lorentzon, C Ohlsson, A Rane and L Ekström

Pharmacogenomics J 7: 282-289; advance online publication, September 19, 2006; doi:10.1038/sj.tpj.6500419

Abstract | Full Text | PDF